Erythromycin 500 mg tablets bulk supplier for pharma manufacturers

Erythromycin 500 Mg Tablets 250 mg, 500 mg, 600 mg Suppliers & Bulk Manufacturers

Available Forms: Oral Tablets/Capsules

Available Strengths: 250 mg, 500 mg, 600 mg

Reference Brands: Erythrocin, Erythrocin V, Erythrocin Stearate(US), Althrocin (India)

Erythromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing translocation. It is effective against respiratory, skin, and soft tissue infections. Benefits include reliable, broad-spectrum activity, good tissue penetration, and convenient oral dosing, making it a trusted choice for treating various bacterial infections.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Erythromycin 500 Mg Tablets? List it or send an offer →

Product Description:

Erythromycin tablets are approved in the EU and US for treating respiratory, skin, and soft tissue bacterial infections. In the EU, brands like Erythrocin and generics are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality standards. In the US, FDA approval relies on extensive clinical data; generic formulations are widely available. Both regions require detailed dossiers, including clinical trial results, manufacturing standards, and pharmacovigilance plans, for approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for erythromycin tablets, ensuring adherence to European and US standards for safe, effective antibiotic therapy.

Erythromycin 500 Mg Tablets — third party manufacturing & bulk supply

Erythromycin 500 Mg Tablets 250 mg, 500 mg, 600 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Erythromycin 500 Mg Tablets is supplied as Oral Tablets/Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Erythromycin 500 Mg Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Erythromycin 500 Mg Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Erythromycin Tablets are used to treat various bacterial infections such as respiratory tract infections, skin infections, throat infections, and certain sexually transmitted infections caused by susceptible bacteria.

Erythromycin Tablets are made from erythromycin or its derivatives such as erythromycin stearate or erythromycin ethylsuccinate combined with pharmaceutical excipients suitable for oral tablet formulations.

Common trade names include Ery-Tab, Erythrocin, Althrocin, Erymax, and Pantomicina.

The original erythromycin brand products such as Ilosone were developed by the pharmaceutical company Eli Lilly and Company, while many pharmaceutical manufacturers worldwide produce generic erythromycin tablets.

The generic name is Erythromycin Tablets.

Common brand names include Ery-Tab, Erythrocin, Althrocin, Erymax, Pantomicina, and Ilosone.

Erythromycin Tablets are manufactured in several countries including the United States, India, the United Kingdom, and various European and Latin American countries by different pharmaceutical manufacturers.